Quinacrine Inhibits Cell Growth and Induces Apoptosis in Human Gastric Cancer Cell Line SGC-7901

Current Therapeutic Research - Clinical and Experimental

Volumn 73, Issue 1-2, 2012, Pages 52-64

  Wu, Xiaoyang ^a,b   Wang, Yunliang ^c   Wang, Hongwei ^d   Wang, Qiang ^d,g   Wang, Lin ^e   Miao, Jingcheng ^f   Cui, Fengmei ^f   Wang, Jinzhi ^f  

^a THE FIRST AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

^b KUNSHAN FIRST PEOPLE S HOSPITAL AFFILIATED TO JIANGSU UNIVERSITY   (China)

^c The 148 Hospital of PLA   (China)

^d UNIVERSITY OF CHICAGO   (United States)

^e Medical College of Shangqiu   (China)

^f SOOCHOW UNIVERSITY   (China)

^g Department of Medicine ^*  (United States)

Author keywords

Apoptosis; Bax; Bcl 2; P53; Quinacrine; SGC 7901 cells

Indexed keywords

ANTINEOPLASTIC AGENT; CASPASE 3; CYTOCHROME C; MEPACRINE; PHOSPHATIDYLSERINE; PROPIDIUM IODIDE; PROTEIN BAX; PROTEIN BCL 2; PROTEIN P53;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER INHIBITION; CELL COUNT; CELL CYCLE PROGRESSION; CELL PROLIFERATION; COLORIMETRY; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; CYTOSOL; CYTOTOXICITY; ENZYME ACTIVITY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IC 50; PRIORITY JOURNAL; STOMACH CANCER; UPREGULATION; WESTERN BLOTTING;

EID: 84863346838     PISSN: 0011393X     EISSN: 18790313     Source Type: Journal    
DOI: 10.1016/j.curtheres.2012.02.003     Document Type: Article

References (31)

1. Wesolowski R., Lee C., Kim R. Is there a role for second-line chemotherapy in advanced gastric cancer?. Lancet Oncol 2009, 10:903-912.
2. Winer E., Gralow J., Diller L., et al. Clinical cancer advances 2008: major research advances in cancer treatment, prevention, and screening-a report from the American Society of Clinical Oncology. J Clin Oncol 2009, 27:812-826.
3. Bozzetti F., Marubini E., Bonfanti G., et al. Subtotal versus total gastrectomy for gastric cancer: five-year survival rates in a multicenter randomized Italian trial. Ann Surg 1999, 230:170-178.
4. Uña E. Gastric cancer: predictors of recurrence when lymph-node dissection is inadequate. World J Surg Oncol 2009, 7:69.
5. Gurova K. New hopes from old drugs: revisiting DNA-binding small molecules as anticancer agents. Future Oncol 2009, 5:1685-1704.
6. Young M.D., Eyles D.E. The efficacy of chloroquine, quinacrine, quinine and totaquine in the treatment of Plasmodium malariae infections (quartan malaria). Am J Trop Med Hyg 1948, 1:93-96.
7. Wolfe M.S. The treatment of intestinal protozoan infections. Med Clin N Am 1982, 66:707-720.
8. Wolfe M.S. Giardiasis. Clin Microbiol Rev 1992, 5:93-100.
9. Wallace D.J. The use of quinacrine (Atabrine) in rheumatic diseases: a reexamination. Semin Arthritis Rheum 1989, 18:282-296.
10. Fasanmade A.A., Owuor E.D., Ee R.P., et al. Quinacrine induces cytochrome c-dependent apoptotic signaling in human cervical carcinoma cells. Arch Pharm Res 2001, 24:126-135.
11. Gurova K.V., Hill J.E., Guo C., et al. Small molecules that reactivate p53 in renal cell carcinoma reveal a NF-kappaB-dependent mechanism of p53 suppression in tumors. Proc Natl Acad Sci U S A 2005, 102:17448-17453.
12. Rossi T., Coppi A., Bruni E., et al. Mepacrine antagonises tumour cell growth induced by natural polyamines. Anticancer Res 2008, 28:2765-2768.
13. Friedman J., Nottingham L., Duggal P., et al. Deficient TP53 expression, function, and cisplatin sensitivity are restored by quinacrine in head and neck cancer. Clin Cancer Res 2007, 13:6568-6578.
14. Briceno E., Reyes S., Sotelo J. Therapy of glioblastoma multiforme improved by the antimutagenic chloroquine. Neurosurg Focus 2003, 14:e3.
15. Wang W., Ho W.C., Dicker D.T., et al. Acridine derivatives activate p53 and induce tumor cell death through Bax. Cancer Biol Ther 2005, 4:893-898.
16. Guo C., Gasparian A.V., Zhuang Z., et al. 9-Aminoacridine-based anticancer drugs target the PI3K/AKT/mTOR, NF-κB and p53 pathways. Oncogene 2009, 28:1151-1161.
17. Wang Y., Bi Q., Dong L., et al. Quinacrine enhances cisplatin-induced cytotoxicity in four cancer cell lines. Chemotherapy 2010, 56:127-134.
18. Agarwal M.L., Agarwal A., Taylor W.R., et al. p53 controls both the G2/M and the G1 cell cycle checkpoints and mediates reversible growth arrest in human fibroblasts. Proc Natl Acad Sci U S A 1995, 92:8493-8497.
19. McCurrach M.E., Connor T.M., Knudson C.M., et al. Bax-deficiency promotes drug resistance and oncogenic transformation by attenuating p53-dependent apoptosis. Proc Natl Acad Sci U S A 1997, 94:2345-2349.
20. Ryan K.M., Phillips A.C., Vousden K.H. Regulation and function of the p53 tumor suppressor protein. Curr Opin Cell Biol 2001, 13:332-337.
21. Deng Y., Wu X. Peg3/Pw1 promotes p53-mediated apoptosis by inducing Bax translocation from cytosol to mitochondria. Proc Natl Acad Sci U S A 2000, 97:12050-12055.
22. Reed J.C. Regulation of apoptosis by bcl-2 family proteins and its role in cancer and chemoresistance. Curr Opin Oncol 1995, 7:541-546.
23. Donovan M., Cotter T.G. Control of mitochondrial integrity by Bcl-2 family members and caspase-independent cell death. Biochim Biophys Acta 2004, 1644:133-147.
24. Murray A.W. Revisiting the cell cycle: cyclins revisited. Cell 2004, 116:221-234.
25. Torres K., Horwitz S.B. Mechanisms of Taxol-induced cell death are concentration dependent. Cancer Res 1998, 58:3620-3626.
26. Pietenpol J.A., Stewart Z.A. Cell cycle checkpoint signaling: cell cycle arrest versus apoptosis. Toxicology 2002, 181182:475-481.
27. Thompson C.B. Apoptosis in the pathogenesis and treatment of disease. Science 1995, 267:1456-1462.
28. Hsu Y.L., Kuo Y.C., Kuo P.L., et al. Apoptotic effects of extract from antrodia camphorate fruiting bodies in human hepatocellular carcinoma cell lines. Cancer Lett 2005, 221:77-89.
29. Wang W., Ho W.C., Dicker D.T., et al. Acridine derivatives activate p53 and induce tumor cell death through Bax. Cancer Biol Ther 2005, 4:893-898.
30. Yang J., Liu X., Bhalla K., et al. Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked. Science 1997, 275:1129-1132.
31. Kluck R.M., Bossy-Wetzel E., Green D.R., et al. The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science 1997, 275:1132-1136.